Bepa Pavlić | Clinical Research | Research Excellence Award

Published on by Awards and Recognitions

Research Excellence Award

Bepa Pavlić
University Hospital Centre Split
Bepa Pavlić
Affiliation University Hospital Centre Split
Country Croatia
Google Scholar bxqWC-YAAAAJ
Documents 10
Citation 1
h-index 1
Subject Area Clinical Research
Event Research Awards and Recognitions
Scopus 60212969000

Bepa Pavlić is a Croatian medical doctor and dermatology researcher affiliated with the University Hospital Centre Split. Her academic and clinical activities focus on dermatology, venereology, hidradenitis suppurativa, psoriasis, dermoscopy, inflammatory skin disorders, and interdisciplinary clinical research. Through conference participation, collaborative publications, and involvement in international dermatological organizations, Pavlić has contributed to emerging clinical discussions concerning inflammatory dermatoses, biologic therapies, and patient-centered dermatological care.[1]

Abstract

This article documents the academic profile, clinical activities, and scholarly contributions of Bepa Pavlić, a Croatian physician specializing in dermatology and venereology. Her work reflects ongoing participation in dermatological education, scientific conferences, interdisciplinary collaborations, and peer-reviewed clinical research. Pavlić has contributed to studies concerning hidradenitis suppurativa, psoriasis, scabies, melanoma, treatment adherence, and inflammatory skin diseases. Her publication portfolio demonstrates engagement with both clinical case reports and translational dermatological research.[2]

Keywords

Dermatology, Venereology, Clinical Research, Psoriasis, Hidradenitis Suppurativa, Melanoma, Dermoscopy, Croatian Medical Research, Biologic Therapy, Academic Medicine.

Introduction

Bepa Pavlić has developed a clinical and academic trajectory within Croatian dermatology through medical practice, conference participation, continuing education, and collaborative scientific publication. Following completion of her Doctor of Medicine degree at the University of Zagreb School of Medicine in 2020, she worked as a general practitioner before commencing specialization in dermatology and venereology at the University Hospital Centre Split in 2022.[3]

Her subsequent enrollment as a PhD candidate at the University of Split School of Medicine reflects an expansion of her academic involvement into research-oriented clinical investigation. Her work spans inflammatory dermatological diseases, dermoscopy, biologic therapy evaluation, treatment adherence, and multidisciplinary patient management.[4]

Research Profile

Pavlić’s academic profile combines clinical dermatology practice with emerging scholarly activity in translational and observational dermatological research. Her participation in scientific meetings across Croatia and Europe has included conferences organized by the European Academy of Dermatology and Venereology (EADV), the European Hidradenitis Suppurativa Foundation (EHSF), and IUSTI Europe.[5]

Her research interests include hidradenitis suppurativa, psoriasis, biologic therapies, melanoma surveillance, skin infections, dermoscopy, and treatment adherence. These themes recur throughout her publications and conference presentations, indicating a sustained interest in evidence-based dermatological practice and patient-centered care models.[6]

In addition to research activity, Pavlić has participated in continuing medical education programs involving infectology, dermoscopy, sexually transmitted infections, skin cancer diagnostics, and advanced dermatovenerology. Such educational participation supports ongoing professional development within specialized dermatological practice.[7]

Research Contributions

Among Pavlić’s notable research contributions are studies examining inflammatory dermatological disorders and biologic therapy outcomes. Collaborative research on hidradenitis suppurativa explored vascular changes associated with adalimumab treatment and investigated systemic therapeutic approaches in severe disease manifestations.[8]

Her publications also address diagnostic dermatology and clinical case management, including reports concerning scabies surrepticius, Bowen’s disease, neuroendocrine tumor-related pruritus, epidermal nevus misdiagnosis, and melanoma surveillance. These works contribute to clinical awareness regarding atypical presentations and multidisciplinary management strategies.[9]

Additional contributions concern psychosocial and behavioral dimensions of dermatological care. Research involving treatment adherence among psoriasis patients and parents of children with atopic dermatitis reflects interest in patient behavior, therapeutic perception, and long-term clinical outcomes.[10]

Publications

  • Removing the Mask of Scabies Surrepticius with Guidelines: A Nodular Scabies Case Report (2023)
  • Is TNF-Alpha Inhibitor Therapy a Good Choice for Patients with Concomitant Hidradenitis Suppurativa and Psoriasis Vulgaris? (2023)
  • Gastrointestinal Neuroendocrine Tumour as a Cause of Pruritus in a Patient with Neurofibromatosis Type 1 (2023)
  • Are We Good Enough in Recognizing Scalp Lesions? (2023)
  • The Effect of Adalimumab Treatment on the Vascularization of Hidradenitis Suppurativa Lesions: A Pilot Study (2024)
  • When Topical Treatment Surprises: A Case Report of Bowen’s Disease in the Perianal Region (2024)
  • Beliefs About Medicines and Adherence to Biologic Therapy in Patients with Moderate-to-Severe Psoriasis: A Cross-Sectional Study (2025)
  • Personality Traits and Treatment Adherence Among Parents of Children with Atopic Dermatitis (2026)
  • Adalimumab Treatment Modulates Vascular Changes in Hidradenitis Suppurativa Lesions in a Sex-Dependent Manner (2026)
  • Bridging Skin and Kidney: IL-17A Blockade for Refractory Hidradenitis Suppurativa in a Hemodialyzed Young Adult (2026)

Research Impact

The research impact associated with Pavlić’s work derives primarily from collaborative clinical publications, participation in specialized dermatological conferences, and contributions to discussions regarding hidradenitis suppurativa, biologic therapy, and dermatological diagnostics. Her work demonstrates engagement with clinically relevant dermatological challenges affecting patient outcomes and therapeutic management.[11]

Her involvement in studies published through journals such as Medicina and Biomedicines further reflects participation in internationally indexed biomedical research dissemination. These activities contribute to the broader exchange of dermatological knowledge within European clinical research networks.[12]

Award Suitability

Bepa Pavlić’s profile aligns with criteria commonly associated with emerging clinical research recognition, particularly in the areas of dermatology, interdisciplinary medical collaboration, and continuing professional development. Her documented engagement with scientific publishing, conference participation, and specialized clinical education indicates sustained scholarly activity within dermatovenerology.[13]

The combination of active clinical service, postgraduate academic development, and participation in international dermatological organizations further supports recognition within research and professional achievement programs focused on early-career medical researchers.[14]

Conclusion

Bepa Pavlić represents an emerging contributor within Croatian and European dermatological research communities. Through collaborative clinical studies, continuing education, scientific conference participation, and interdisciplinary publication activity, her work reflects ongoing engagement with contemporary dermatological challenges and evidence-based medical practice. Her academic progression and clinical research participation position her within a growing network of physician-researchers contributing to advances in dermatology and venereology.[15]

References

  1. Google Scholar. (n.d.). Bepa Pavlić Scholar Profile. https://scholar.google.com/citations?user=bxqWC-YAAAAJ&hl=en&oi=sra
  2. Elsevier. (n.d.). Scopus author details: Bepa Pavlić, Author ID 60212969000. Scopus. https://www.scopus.com/authid/detail.uri?authorId=60212969000
  3. University of Zagreb School of Medicine. (2020). Doctor of Medicine Graduation Record.
  4. University of Split School of Medicine. (2025). PhD Candidate Enrollment Information.
  5. European Academy of Dermatology and Venereology (EADV). (2023). Professional Membership Information. https://www.eadv.org/
  6. European Hidradenitis Suppurativa Foundation. (2024). Conference and Research Activities. https://ehsf.eu/
  7. University Hospital Centre Split. (2022–2026). Continuing Medical Education and Dermatology Training Activities.
  8. Vuković, D., Pavlić, B., et al. (2024). The Effect of Adalimumab Treatment on the Vascularization of Hidradenitis Suppurativa Lesions: A Pilot Study.
  9. Pavlić, B., et al. (2024). When Topical Treatment Surprises: A Case Report of Bowen’s Disease in the Perianal Region.
  10. Pavić, M., et al. (2025). Beliefs About Medicines and Adherence to Biologic Therapy in Patients with Moderate-to-Severe Psoriasis: A Cross-Sectional Study. https://doi.org/10.3390/medicina61010001
  11. Pavlić, B., et al. (2026). Adalimumab Treatment Modulates Vascular Changes in Hidradenitis Suppurativa Lesions in a Sex-Dependent Manner. Biomedicines. https://doi.org/10.3390/biomedicines14010001
  12. MDPI. (2026). Biomedicines Special Issue: Pathophysiology and Therapeutic Innovations in Skin and Appendage Disorders. https://www.mdpi.com/journal/biomedicines
  13. Research Awards and Recognitions. (n.d.). Academic Recognition and Research Excellence Programs. https://awardsandrecognitions.com/
  14. Croatian Dermatovenerological Society. (2023). Professional Society Membership Record.
  15. European clinical dermatology conference proceedings and collaborative publications associated with Bepa Pavlić between 2023 and 2026.